Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

[Contribution of Doppler ultrasound for the diagnosis of giant cell arteritis].

Rinagel M, Chatelus E, Arnaud L, Jousse-Joulin S.

Presse Med. 2019 Sep;48(9):941-947. doi: 10.1016/j.lpm.2019.06.004. Epub 2019 Jul 18. Review. French.

PMID:
31327543
2.

T1 mapping cardiac magnetic resonance imaging frequently detects subclinical diffuse myocardial fibrosis in systemic sclerosis patients.

Poindron V, Chatelus E, Canuet M, Gottenberg JE, Arnaud L, Gangi A, Gavand PE, Guffroy A, Korganow AS, Germain P, Sibilia J, El Ghannudi S, Martin T.

Semin Arthritis Rheum. 2019 Jun 19. pii: S0049-0172(18)30711-X. doi: 10.1016/j.semarthrit.2019.06.013. [Epub ahead of print]

3.

Single tumor-like tophus.

Messer L, Duret PM, Mallick A, Willaume T, Spielmann L, Chatelus E.

Joint Bone Spine. 2019 Jul;86(4):509-510. doi: 10.1016/j.jbspin.2019.02.002. Epub 2019 Feb 14. No abstract available.

PMID:
30772488
4.

Diagnostic performance of temporal artery ultrasound for the diagnosis of giant cell arteritis: a systematic review and meta-analysis of the literature.

Rinagel M, Chatelus E, Jousse-Joulin S, Sibilia J, Gottenberg JE, Chasset F, Arnaud L.

Autoimmun Rev. 2019 Jan;18(1):56-61. doi: 10.1016/j.autrev.2018.07.012. Epub 2018 Nov 5.

PMID:
30408588
5.

Prospective evaluation of the frequency of genital lichen sclerosus in 79 patients with systemic sclerosis.

Goussot R, Francès C, Cury K, Bessis D, Martin T, Chatelus E, Mahé A, Messer L, Séverac F, Meyer N, Lipsker D.

Br J Dermatol. 2018 Oct;179(4):999-1000. doi: 10.1111/bjd.16898. Epub 2018 Jul 26. No abstract available.

PMID:
29928761
6.

Patient acceptable symptom state and minimal clinically important difference for patient-reported outcomes in systemic sclerosis: A secondary analysis of a randomized controlled trial comparing personalized physical therapy to usual care.

Daste C, Rannou F, Mouthon L, Sanchez K, Roren A, Tiffreau V, Hachulla É, Thoumie P, Cabane J, Chatelus E, Sibilia J, Poiraudeau S, Nguyen C.

Semin Arthritis Rheum. 2019 Feb;48(4):694-700. doi: 10.1016/j.semarthrit.2018.03.013. Epub 2018 Mar 27.

PMID:
29685482
7.

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients.

Danion F, Sparsa L, Arnaud L, Alsaleh G, Lefebvre F, Gies V, Martin T, Lukas C, Durckel J, Ardizzone M, Javier RM, Kleinmann JF, Moreau P, Blaison G, Goetz J, Chatelus E, Gottenberg JE, Sibilia J, Sordet C.

RMD Open. 2017 Dec 29;3(2):e000555. doi: 10.1136/rmdopen-2017-000555. eCollection 2017.

8.

Mapping and predicting mortality from systemic sclerosis.

Elhai M, Meune C, Boubaya M, Avouac J, Hachulla E, Balbir-Gurman A, Riemekasten G, Airò P, Joven B, Vettori S, Cozzi F, Ullman S, Czirják L, Tikly M, Müller-Ladner U, Caramaschi P, Distler O, Iannone F, Ananieva LP, Hesselstrand R, Becvar R, Gabrielli A, Damjanov N, Salvador MJ, Riccieri V, Mihai C, Szücs G, Walker UA, Hunzelmann N, Martinovic D, Smith V, Müller CS, Montecucco CM, Opris D, Ingegnoli F, Vlachoyiannopoulos PG, Stamenkovic B, Rosato E, Heitmann S, Distler JHW, Zenone T, Seidel M, Vacca A, Langhe E, Novak S, Cutolo M, Mouthon L, Henes J, Chizzolini C, Mühlen CAV, Solanki K, Rednic S, Stamp L, Anic B, Santamaria VO, De Santis M, Yavuz S, Sifuentes-Giraldo WA, Chatelus E, Stork J, Laar JV, Loyo E, García de la Peña Lefebvre P, Eyerich K, Cosentino V, Alegre-Sancho JJ, Kowal-Bielecka O, Rey G, Matucci-Cerinic M, Allanore Y; EUSTAR group.

Ann Rheum Dis. 2017 Nov;76(11):1897-1905. doi: 10.1136/annrheumdis-2017-211448. Epub 2017 Aug 23.

PMID:
28835464
9.

Lumbar Spine Chondrocalcinosis.

Petit H, Marcellin L, Chatelus E.

J Rheumatol. 2017 Aug;44(8):1288-1289. doi: 10.3899/jrheum.161452. No abstract available.

PMID:
28765345
10.

Intravenous immunoglobulins in systemic sclerosis: Data from a French nationwide cohort of 46 patients and review of the literature.

Sanges S, Rivière S, Mekinian A, Martin T, Le Quellec A, Chatelus E, Lescoat A, Jego P, Cazalets C, Quéméneur T, Le Gouellec N, Senet P, Francès C, Deroux A, Imbert B, Fain O, Boukari L, Sené T, Deligny C, Mathian A, Agard C, Pugnet G, Speca S, Dubucquoi S, Hatron PY, Hachulla É, Launay D.

Autoimmun Rev. 2017 Apr;16(4):377-384. doi: 10.1016/j.autrev.2017.02.008. Epub 2017 Feb 13. Review.

PMID:
28232167
11.

[Discontinuation or tapering strategies of biologics in rheumatoid arthritis in remission].

Mallick A, Fautrel B, Sagez F, Sordet C, Javier RM, Petit H, Chatelus E, Rahal N, Gottenberg JE, Sibilia J.

Rev Med Interne. 2017 Apr;38(4):256-263. doi: 10.1016/j.revmed.2016.12.014. Epub 2017 Feb 1. Review. French.

PMID:
28161110
12.

Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening.

Lazzaroni MG, Cavazzana I, Colombo E, Dobrota R, Hernandez J, Hesselstrand R, Varju C, Nagy G, Smith V, Caramaschi P, Riccieri V, Hachulla E, Balbir-Gurman A, Chatelus E, Romanowska-Próchnicka K, Araújo AC, Distler O, Allanore Y, Airò P; EUSTAR co-authors.

J Rheumatol. 2017 May;44(5):639-647. doi: 10.3899/jrheum.160817. Epub 2017 Jan 15.

PMID:
28089973
13.

Personalized Physical Therapy Versus Usual Care for Patients With Systemic Sclerosis: A Randomized Controlled Trial.

Rannou F, Boutron I, Mouthon L, Sanchez K, Tiffreau V, Hachulla E, Thoumie P, Cabane J, Chatelus E, Sibilia J, Roren A, Berezne A, Baron G, Porcher R, Guillevin L, Ravaud P, Poiraudeau S.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):1050-1059. doi: 10.1002/acr.23098. Epub 2017 Jun 7.

14.

Efficacy of abatacept in systemic lupus erythematosus: a retrospective analysis of 11 patients with refractory disease.

Danion F, Rosine N, Belkhir R, Gottenberg JE, Hachulla E, Chatelus E, Pugnet G, Pers YM, Mariette X, Sibilia J, Seror R; Club Rhumatismes et Inflammation section of the French Society of Rheumatology.

Lupus. 2016 Nov;25(13):1440-1447. doi: 10.1177/0961203316640911. Epub 2016 Jul 11.

PMID:
27013663
15.

Brief Report: Spatial Heterogeneity of Systemic Sclerosis in France: High Prevalence in the Northeast Region.

Meyer A, Chifflot H, Chatelus E, Kleinmann JF, Ronde-Ousteau C, Klein D, Jégu J, Geny B, Hirshi S, Canuet M, Blaison G, Kieffer P, Lipsker D, Martin T, Sauleau E, Velten M, Sibilia J.

Arthritis Rheumatol. 2016 Jul;68(7):1731-7. doi: 10.1002/art.39613.

16.

High reactive oxygen species in fibrotic and nonfibrotic skin of patients with diffuse cutaneous systemic sclerosis.

Bourji K, Meyer A, Chatelus E, Pincemail J, Pigatto E, Defraigne JO, Singh F, Charlier C, Geny B, Gottenberg JE, Punzi L, Cozzi F, Sibilia J.

Free Radic Biol Med. 2015 Oct;87:282-9. doi: 10.1016/j.freeradbiomed.2015.07.002. Epub 2015 Jul 2.

PMID:
26143738
17.

Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study.

Hachulla E, Hatron PY, Carpentier P, Agard C, Chatelus E, Jego P, Mouthon L, Queyrel V, Fauchais AL, Michon-Pasturel U, Jaussaud R, Mathian A, Granel B, Diot E, Farge-Bancel D, Mekinian A, Avouac J, Desmurs-Clavel H, Clerson P; SEDUCE study group.

Ann Rheum Dis. 2016 Jun;75(6):1009-15. doi: 10.1136/annrheumdis-2014-207001. Epub 2015 May 20.

18.

Chloroma--an uncommon cause of arthritis.

Guffroy A, Helali M, Merle B, Imperiale A, Chatelus E.

Arthritis Rheumatol. 2015 May;67(8):2239. doi: 10.1002/art.39172. No abstract available.

19.

Outcome of hepatitis E virus infection in patients with inflammatory arthritides treated with immunosuppressants: a French retrospective multicenter study.

Bauer H, Luxembourger C, Gottenberg JE, Fournier S, Abravanel F, Cantagrel A, Chatelus E, Claudepierre P, Hudry C, Izopet J, Fabre S, Lefevre G, Marguerie L, Martin A, Messer L, Molto A, Pallot-Prades B, Pers YM, Roque-Afonso AM, Roux C, Sordet C, Soubrier M, Veissier C, Wendling D, Péron JM, Sibilia J; Club Rhumatismes et Inflammation, a section of the French Society of Rheumatology.

Medicine (Baltimore). 2015 Apr;94(14):e675. doi: 10.1097/MD.0000000000000675.

20.

When biologics should be used in systemic lupus erythematosus?

Gottenberg JE, Lorenzo N, Sordet C, Theulin A, Chatelus E, Sibilia J.

Presse Med. 2014 Jun;43(6 Pt 2):e181-5. doi: 10.1016/j.lpm.2014.04.006. Epub 2014 Jun 3. Review.

PMID:
24933678
21.

Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.

Agard C, Carpentier PH, Mouthon L, Clerson P, Gressin V, Bérezné A, Diot E, Jego P, Lok C, Sparsa A, Chatelus E, Van Kien AK, Quéré I, Sibilia J, Hachulla E.

Scand J Rheumatol. 2014;43(5):398-402. doi: 10.3109/03009742.2014.887768. Epub 2014 Apr 11.

PMID:
24720440
22.

Classification criteria and treatment modalities in primary Sjögren's syndrome.

Fazaa A, Bourcier T, Chatelus E, Sordet C, Theulin A, Sibilia J, Gottenberg JE.

Expert Rev Clin Immunol. 2014 Apr;10(4):543-51. doi: 10.1586/1744666X.2014.897230. Review.

PMID:
24646087
23.

B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis.

François A, Chatelus E, Wachsmann D, Sibilia J, Bahram S, Alsaleh G, Gottenberg JE.

Arthritis Res Ther. 2013 Oct 28;15(5):R168. doi: 10.1186/ar4352.

24.

Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects.

Grimaldi-Bensouda L, Guillemot D, Godeau B, Bénichou J, Lebrun-Frenay C, Papeix C, Labauge P, Berquin P, Penfornis A, Benhamou PY, Nicolino M, Simon A, Viallard JF, Costedoat-Chalumeau N, Courcoux MF, Pondarré C, Hilliquin P, Chatelus E, Foltz V, Guillaume S, Rossignol M, Abenhaim L; PGRx-AID Study Group.

J Intern Med. 2014 Apr;275(4):398-408. doi: 10.1111/joim.12155. Epub 2013 Nov 22.

25.

In antisynthetase syndrome, amyloidosis is rare and might not be related to the disease.

Meyer A, Theulin A, Chatelus E, Sordet C, Javier RM, Marcelin L, Goetz J, Geny B, Sibilia J, Gottenberg JE.

Amyloid. 2012 Dec;19(4):214-6. doi: 10.3109/13506129.2012.733742. Epub 2012 Oct 30. No abstract available.

PMID:
23106498
26.

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.

Prey S, Ezzedine K, Doussau A, Grandoulier AS, Barcat D, Chatelus E, Diot E, Durant C, Hachulla E, de Korwin-Krokowski JD, Kostrzewa E, Quemeneur T, Paul C, Schaeverbeke T, Seneschal J, Solanilla A, Sparsa A, Bouchet S, Lepreux S, Mahon FX, Chene G, Taïeb A.

Br J Dermatol. 2012 Nov;167(5):1138-44. doi: 10.1111/j.1365-2133.2012.11186.x. Epub 2012 Oct 5.

PMID:
23039171
27.

Improving agreement in assessment of synovitis in rheumatoid arthritis.

Cheung PP, Dougados M, Andre V, Balandraud N, Chales G, Chary-Valckenaere I, Chatelus E, Dernis E, Gill G, Gilson M, Guis S, Mouterde G, Pavy S, Pouyol F, Marhadour T, Richette P, Ruyssen-Witrand A, Soubrier M, Gossec L.

Joint Bone Spine. 2013 Mar;80(2):155-9. doi: 10.1016/j.jbspin.2012.07.014. Epub 2012 Sep 19.

PMID:
22999909
28.

Campylobacter fetus infection in three rheumatoid arthritis patients treated with rituximab.

Meyer A, Theulin A, Chatelus E, Argemi X, Sordet C, Javier RM, Hansmann Y, Sibilia J, Gottenberg JE.

Ann Rheum Dis. 2012 Jun;71(6):1094-5. doi: 10.1136/annrheumdis-2011-200719. Epub 2012 Feb 1. No abstract available.

PMID:
22302315
29.

Pulmonary arterial hypertension during systemic lupus.

Cinquetti G, Sordet C, Chatelus E, Ronde-Oustau C, Javier RM, Gottenberg JE, Sibilia J.

Joint Bone Spine. 2012 Mar;79(2):205-6. doi: 10.1016/j.jbspin.2011.09.019. Epub 2012 Jan 28. No abstract available.

PMID:
22284612
30.

Whipple limbic encephalitis.

Blanc F, Ben Abdelghani K, Schramm F, Jaulhac B, Chatelus E, Sordet C, Gottenberg JE, Sibilia J.

Arch Neurol. 2011 Nov;68(11):1471-3. doi: 10.1001/archneurol.2011.532.

PMID:
22084133
31.

Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis.

Meyer A, Chatelus E, Wendling D, Berthelot JM, Dernis E, Houvenagel E, Morel J, Richer O, Schaeverbeke T, Gottenberg JE, Sibilia J; Club Rhumatisme et Inflammation.

Arthritis Rheum. 2011 May;63(5):1274-80. doi: 10.1002/art.30272.

32.

Paraneoplastic polymyositis associated with breast cancer: a therapeutic emergency.

Croce S, Guèye M, Korganow AC, Chatelus E, Guèye SM, Diemunsch P, Mathelin C.

Breast Cancer Res Treat. 2011 Apr;126(3):811-4. doi: 10.1007/s10549-010-1328-7. Epub 2011 Jan 6.

PMID:
21210207
33.

[How can we diagnose and better understand inflammatory myopathies? The usefulness of auto-antibodies].

Sibilia J, Chatelus E, Meyer A, Gottenberg JE, Sordet C, Goetz J.

Presse Med. 2010 Oct;39(10):1010-25. doi: 10.1016/j.lpm.2010.06.008. Epub 2010 Jul 23. French.

PMID:
20655695
34.

Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis.

Alsaleh G, Sparsa L, Chatelus E, Ehlinger M, Gottenberg JE, Wachsmann D, Sibilia J.

Arthritis Res Ther. 2010;12(4):R135. doi: 10.1186/ar3073. Epub 2010 Jul 8.

35.

Multicentric reticulohistiocytosis: an autoimmune systemic disease? Case report of an association with erosive rheumatoid arthritis and systemic Sjogren syndrome.

Ben Abdelghani K, Mahmoud I, Chatelus E, Sordet C, Gottenberg JE, Sibilia J.

Joint Bone Spine. 2010 May;77(3):274-6. doi: 10.1016/j.jbspin.2010.03.006.

PMID:
20435499
36.

Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?

Sparsa L, Afif N, Goetz J, Sordet C, Chatelus E, Lipsker D, Sibilia J.

Rheumatol Int. 2011 Feb;31(2):255-8. doi: 10.1007/s00296-009-1169-z. Epub 2009 Oct 13.

PMID:
19823837
37.

Incidence and prevalence of systemic sclerosis: a systematic literature review.

Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J.

Semin Arthritis Rheum. 2008 Feb;37(4):223-35. Epub 2007 Aug 9. Review.

PMID:
17692364
38.

Nocardia discitis in an immunocompetent patient.

Chatelus E, Javier RM, Sibilia J, Kuntz JL, Forestier E, Gaudias J.

Joint Bone Spine. 2007 Mar;74(2):207-9. Epub 2007 Feb 2. No abstract available.

PMID:
17360219

Supplemental Content

Loading ...
Support Center